Social Clips

Scleroderma in Children

In this video from the Hospital for Special Surgery, learn more about children and scleroderma. “Many do not realize that this is not a disease exclusive to adults. Dr. Thomas Lehman, Chief of Pediatric Rheumatology, explains the signs and symptoms of scleroderma, as well as when you should seek…

Scleroderma: Searching for the Cause and the Cure

In this video from the Scleroderma Foundation, Greater Chicago Chapter, listen to Maureen D. Mayes, MD, MPH present at the Scleroderma Patient Education Conference, October 19, 2013 at Northwestern Memorial Hospital. Learn more about scleroderma here: http://bit.ly/learnscleroderma…

#TBT – Bob Saget on Scleroderma Research Foundation Benefit

“Reality Cares TV interviews Bob Saget, host of the Scleroderma Research Foundation Benefit on May 25, 2010, Cool Comedy – Hot Cuisine.” Learn more about scleroderma here. Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or…

What is Scleroderma?

https://www.youtube.com/watch?v=2SZenSAMexo In this video from Arthritis Research UK, learn the basics of Scleroderma. Learn more about scleroderma here: http://bit.ly/learnscleroderma…

How Do We Track Vascular Changes in a Scleroderma Clinic?

In this session, Dr. Tracy Frech will review the different clinical tools that your physician can use to assess your vascular health. The clinical use of blood pressure monitoring, capillaroscopy, echocardiography, and sublingual blood flow measurements will be discussed. This session was recorded in Nashville during the 2015 Scleroderma…

Scleroderma and its Connection to PAH

In this video from PAH.tv learn more about Scleroderma and its connection to pulmonary arterial hypertension (PAH). “Tracy Sperry, National Director of Development and Research for the Scleroderma Foundation, discusses the mission of the organization and scleroderma’s role in PAH. Recorded at the 2014 American Thoracic Society meeting in San…

OFEV to be Tested in Scleroderma Patients with Interstitial Lung Disease

Boehringer Ingelheim recently announced the enrollment of the first patient in the Phase 3 clinical trial SENSCIS (Safety and Efficacy of Nintedanib in Systemic SClerosIS) evaluating the safety and efficacy of the company’s product nintedanib (OFEV) in patients with systemic sclerosis and interstitial lung disease. Watch video above to learn…

Unleashing Your Unsinkable Spirit by Cindy Coney

In this video from the Scleroderma Foundation, watch “Unleashing Your Unsinkable Spirit” by Cindy Coney, a keynote speech from the 2015 Scleroderma Foundation National Patient Education Conference for patients with the chronic illness and those who love and care for them. Receiving a diagnosis of a life-challenging illness can…